People
Chinese researcher He Jiankui earlier reported that a set of twins had been born who underwent CRISPR gene editing as fetuses. He followed up last night, stating that another one of the seven couples he experimented on is pregnant.
Bill Wright, who most recently led SynDaver’s European operations, has assumed global responsibilities previously managed by SynDaver CEO, Dr. Christopher Sakezles. This leadership change will enable Sakezles to be wholly focused on SynDaver’s new research and development operations under sister company, SynDaverX.
Steven Fang, executive director of Invitrocue with offices in Australia, China and Singapore, took time to talk to BioSpace about the company and the Asian market for biopharma.
Toward the end of every year, biopharma executives are asked to dust off their crystal balls and predict what the next year might reveal. It’s that time of year again! Find out what execs are saying about M&A, gene therapy, sickle cell, and more.
Abeona did not specify the type of misconduct that Carsten Thiel engaged in, but it was serious enough to warrant termination.
Oculis announces the appointments of Fabio Baschiera PharmD, MPh, Ph.D. as Vice President of Clinical Development, and Louie-Anne Gauthier M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing.
Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology
Peer review has a long history behind it, and it has since become synonymous with the scientific method. Ever since its original inception in the 18th century, the peer review process has undergone many changes in its evolution to what it is now.
MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany, handed out $30,000 to three graduate students for their research projects.
Clinigen Group plc announces that Professor Alan Boyd has been appointed as a Non-Executive Director with immediate effect.
PRESS RELEASES